These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25074946)

  • 1. Rhode Island's opioid epidemic response features collaborative practice model.
    Traynor K
    Am J Health Syst Pharm; 2014 Aug; 71(16):1328-32. PubMed ID: 25074946
    [No Abstract]   [Full Text] [Related]  

  • 2. The Rhode Island community responds to opioid overdose deaths.
    Bowman S; Engelman A; Koziol J; Mahoney L; Maxwell C; McKenzie M
    R I Med J (2013); 2014 Oct; 97(10):34-7. PubMed ID: 25271658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responding to opioid overdose in Rhode Island: where the medical community has gone and where we need to go.
    Green TC; Bratberg J; Dauria EF; Rich JD
    R I Med J (2013); 2014 Oct; 97(10):29-33. PubMed ID: 25271657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency department naloxone distribution: a Rhode Island department of health, recovery community, and emergency department partnership to reduce opioid overdose deaths.
    Samuels E
    R I Med J (2013); 2014 Oct; 97(10):38-9. PubMed ID: 25271659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing take-home naloxone in an urban community pharmacy.
    Akers JL; Hansen RN; Oftebro RD
    J Am Pharm Assoc (2003); 2017; 57(2S):S161-S167. PubMed ID: 28202384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.
    Green TC; Dauria EF; Bratberg J; Davis CS; Walley AY
    Harm Reduct J; 2015 Aug; 12():25. PubMed ID: 26245865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State Unintentional Drug Overdose Reporting Surveillance: Opioid Overdose Deaths and Characteristics in Rhode Island.
    Jiang Y; McDonald JV; Goldschmidt A; Koziol J; McCormick M; Viner-Brown S; Alexander-Scott N
    R I Med J (2013); 2018 Sep; 101(7):25-30. PubMed ID: 30189700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Use of a New Opioid Overdose Surveillance System, 2016.
    McCormick M; Koziol J; Sanchez K
    R I Med J (2013); 2017 Apr; 100(4):37-39. PubMed ID: 28375419
    [No Abstract]   [Full Text] [Related]  

  • 9. The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island.
    Zaller ND; Yokell MA; Green TC; Gaggin J; Case P
    Subst Use Misuse; 2013 Jun; 48(8):590-9. PubMed ID: 23750660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of opioid overdose: a brief review of naloxone pharmacology and delivery.
    Hendley TM; Hersh EV; Moore PA; Stahl B; Saraghi M
    Gen Dent; 2017; 65(3):18-21. PubMed ID: 28475079
    [No Abstract]   [Full Text] [Related]  

  • 11. A nationwide pharmacy chain responds to the opioid epidemic.
    Shafer E; Bergeron N; Smith-Ray R; Robson C; O'Koren R
    J Am Pharm Assoc (2003); 2017; 57(2S):S123-S129. PubMed ID: 28163028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the Opioid Epidemic in Rhode Island: Where Are We Missing Resources?
    Schneider R; Carlson L; Rosenthal S
    R I Med J (2013); 2020 Feb; 103(1):46-50. PubMed ID: 32013306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portrait of an epidemic: acute opioid intoxication in adults.
    Strickler J; James A; Oʼleary S; Dube-Clark G
    Nursing; 2018 Sep; 48(9):40-43. PubMed ID: 30134319
    [No Abstract]   [Full Text] [Related]  

  • 14. What is known about community pharmacy supply of naloxone? A scoping review.
    Nielsen S; Van Hout MC
    Int J Drug Policy; 2016 Jun; 32():24-33. PubMed ID: 26949189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NaloxBox Program in Rhode Island: A Model for Community-Access Naloxone.
    Capraro GA; Rebola CB
    Am J Public Health; 2018 Dec; 108(12):1649-1651. PubMed ID: 30403513
    [No Abstract]   [Full Text] [Related]  

  • 16. Pennsylvania law enforcement use of Narcan.
    Jacoby JL; Crowley LM; Cannon RD; Weaver KD; Henry-Morrow TK; Henry KA; Kayne AN; Urban CE; Gyory RA; McCarthy JF
    Am J Emerg Med; 2020 Sep; 38(9):1944-1946. PubMed ID: 32057531
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.
    Stopka TJ; Donahue A; Hutcheson M; Green TC
    J Am Pharm Assoc (2003); 2017; 57(2S):S34-S44. PubMed ID: 28189540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings from Bridging Health Disparities to Address the Opioid Epidemic: A Symposium at the Warren Alpert Medical School of Brown University.
    Dumenco L; Monteiro K; Mello M; Collins S; Operario D; Scanlan K; Dollase R; George P
    R I Med J (2013); 2017 Apr; 100(4):16-18. PubMed ID: 28375414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone Conundrum: Reduce risk in managing the opioid overdose patient.
    Wirth SR
    JEMS; 2016 Nov; 41(11):14-5. PubMed ID: 29188938
    [No Abstract]   [Full Text] [Related]  

  • 20. Distribution of naloxone for overdose prevention to chronic pain patients.
    Coe MA; Walsh SL
    Prev Med; 2015 Nov; 80():41-3. PubMed ID: 26024850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.